← Leaderboards
Walter J Urba
Providence Portland Medical Center
$2,009,864
Attributed
$2,009,864
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $326.9K · FY2005–09$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,009,864 · 4
By mechanism
R21$2,009,864 · 4
Top collaborators
No co-investigators on record.
Most similar at Providence Portland Medical Center
Same institution · by research overlap
- Brendan D Curti$3,242,071
- William L Redmond$2,939,722
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsNeoplasm /Cancer VaccineHuman SubjectSynthetic VaccinesCytokineFlow CytometryClinical ResearchMelanomaHuman Therapy EvaluationPatient Oriented ResearchNeoplasm /Cancer ImmunotherapyCytotoxic T LymphocyteLeukocyte Activation /TransformationEnzyme Linked Immunosorbent AssayCancer ControlCancer CellAntigen TargetingBullaAntigensAmericanDendritic CellsChemotherapyAbstractingCessation Of Life
Grant awards (7)
Clinical Trial of DRibble Vaccine in NSCLC$326,925
R21 · FY2009 · CA · contact PI
Clinical Trial of DRibble Vaccine in NSCLC$326,925
R21 · FY2008 · CA · contact PI
Peptide Booster Vaccination in A2+ Melanoma Patients$291,715
R21 · FY2005 · CA
gp100 Peptide Immunization after Lymphocyte Depletion$316,618
R21 · FY2004 · CA
Peptide Booster Vaccination in A2+ Melanoma Patients$291,715
R21 · FY2004 · CA
gp100 Peptide Immunization after Lymphocyte Depletion$316,618
R21 · FY2003 · CA
IMMUNE RESPONSE TO THE MUTATED GP?00 PEPTIDE (209O-2M)$139,348
R21 · FY2000 · CA